IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. 

Biotechnology

IO Biotech

Mai-Britt Zocca

Misbah Sherwani

Qasim Ahmad

Devin Smith

Eric Faulkner

Amy Sullivan

Brian Burkavage

Ayako Wakatsuki Pedersen

Margaret Siemon-Hryczyk

Dan Mannix

Diane Mcdowell

Muhammad Al-Hajj

The Clinical Operations Team at IO Biotech is responsible for the planning, execution, and management of clinical trials to evaluate the efficacy and safety of the company's novel immune therapies for cancer. This team ensures regulatory compliance, oversees data collection and management, and collaborates with various stakeholders to facilitate successful clinical development programs.

Clinical Operations Team

Research and Development

Regulatory and Clinical Operations

Clinical Operations Team

About

Team members

Other teams at IO Biotech

Research and Development

Regulatory and Clinical Operations